Drug Formulary Management Market Size is predicted to grow at a 5.9% CAGR during the forecast period for 2024-2031.
Drug formulary management is a system used in healthcare to ensure that patients are prescribed the safest, most effective, and most affordable medications. It's essentially a list of approved medications that a healthcare organization, like a hospital or insurance plan, recommends for use by doctors. This list is based on scientific evidence, expert opinions, and cost considerations. A committee of healthcare professionals, typically pharmacists and physicians, oversee the formulary. A group of healthcare professionals, including physicians, pharmacists, and other experts, reviews and evaluates clinical data to make informed decisions on which drugs should be included in the formulary.
This committee, known as the Pharmacy and Therapeutics (P&T) committee, ensures that the formulary reflects current best practices and clinical guidelines. By carefully assessing the safety, efficacy, and cost-effectiveness of medications, they maintain a formulary that supports optimal patient care while promoting consistency and standardization in prescribing practices within the healthcare organization. By promoting the use of safe and effective medications, drug formulary management helps ensure patients receive the best possible treatment. By focusing on cost-effective options, it can help control healthcare spending, making high-quality care more accessible and sustainable. Additionally, formulary management ensures consistency in prescribing practices within a healthcare organization, leading to standardized care that aligns with the latest clinical guidelines and evidence-based practices.
The increasing cost of healthcare services and medications drives the need for efficient formulary management to control expenses and ensure affordability for patients and healthcare systems. There is a growing emphasis on cost-effective treatment options. Formulary management helps in identifying and promoting the use of generic and biosimilar drugs, which are often less expensive alternatives to brand-name medications.
Competitive Landscape
Some of the Major Key Players in the Drug Formulary Management Market are
- FDB (First Databank)
- Evernorth Health, Inc.
- Wolters Kluwer Medi-Span
- Academy of Managed Care Pharmacy
- McKesson
- Salesforce
- Pharmacy Purchasing & Products
- VativoRx
- Nuwae
- MedReb8
- Other Companies
Market Segmentation:
The Controlled Formulary Segment Dominate the Market
Based on the by type, the market divided into open formulary, closed formulary, and controlled formulary. Among these, the controlled formulary segment dominates the market. A controlled formulary strikes a balance between open and closed formularies. It includes a tiered structure where certain drugs are preferred and covered at different levels, incorporating utilization management tools like prior authorization and step therapy. Controlled formularies tend to be dominant in the market overall, as they offer a compromise between cost containment and flexibility. They are widely used by private insurers, large health systems, and pharmacy benefit managers (PBMs) to manage costs while maintaining a degree of flexibility for physicians and patients.
The Managed Care Organization (MCO) Formulary Management Segment is Expected to have the highest growth rate during the forecast period
The by application type categorized into hospital formulary management and managed care organization (MCO) formulary management. Among these, the managed care organization (MCO) formulary management segment is expected to have the highest growth rate during the forecast period. MCOs cover a wide array of settings, including outpatient, inpatient, and pharmacy services, leading to broader adoption and integration of formulary management practices. This comprehensive coverage across various aspects of healthcare has driven a significant rise in enrollment in managed care plans, such as Health Maintenance Organizations (HMOs) and Preferred Provider Organizations (PPOs), fueled by both government programs (Medicare and Medicaid) and private insurers.
North America Led the Drug Formulary Management Market
North America has a large and diverse pharmaceutical market, with extensive research and development activities, leading to a wide range of medications available for inclusion in formularies. Moreover, stringent regulatory frameworks and guidelines ensure the safety, efficacy, and cost-effectiveness of drugs included in formularies, enhancing confidence in their utilization. The region's focus on cost containment, coupled with a growing emphasis on value-based care models, further drives the adoption of formulary management strategies to optimize healthcare spending while ensuring quality patient care.
Recent Developments:
- In May 2023, the two group buying organizations (GPOs) that handle prescription rebate negotiations on behalf of other PBMs were subject to mandatory directives from the Federal Trade Commission (FTC). The FTC also said that it is still looking into pharmacy benefit managers (PBMs) and how they affect the affordability and accessibility of prescription drugs. These orders, which demanded extensive documentation and information on Zinc Health Services, LLC and Ascent Health Services, LLC's business procedures, were given to both companies. The FTC's mandatory directives to the six biggest PBMs in the US healthcare market were followed by this action. These PBMs, which are frequently a component of vertically integrated businesses, acted as middlemen in the negotiations of fees and rebates with pharmaceutical firms, the creation of drug formularies, and the payment of pharmacies for filling prescriptions for patients.
- In Sept. 2022,Evernorth, Cigna Corporation's health services division has added five new app-based programs to its Digital Health Formulary to assist individuals in managing their inflammatory illnesses, anxiety, alcohol and opioid use disorders, and sleep problems. Evernorth's Digital Health Formulary is a clinically based platform of verified, reliable health apps in a busy digital health industry that helps people reach their health goals.
Drug Formulary Management Market Report Scope
Report Attribute |
Specifications |
Growth Rate CAGR |
CAGR of 5.9% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Type, By Application Type |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
Competitive Landscape |
FDB (First Databank), Evernorth Health, Inc., Wolters Kluwer Medi-Span, Academy of Managed Care Pharmacy, McKesson, Salesforce Pharmacy Purchasing & Products, VativoRx, Nuwae, MedReb8, Other Companies |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |